Ximelagatran anticoagulent drug molecule

Ximelagatran anticoagulent drug molecule

A624/0233 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 38.4MB

Downloadable file size: 630.1KB

Price image Pricing

Please login to use the price calculator


Caption: Ximelagatran anticoagulant drug. Molecular model showing the structure of the anticoagulant drug ximelagatran (marketed as Exanta). Atoms are represented as rods and colour-coded: carbon (yellow), hydrogen (white), nitrogen (green) and oxygen (blue). Ximelagatran is used to treat blood clotting disorders. It belongs to a class of drugs known as direct thrombin inhibitors and is the first of these drugs to be available in oral form. Ximelagatran is converted in the body to melagatran, a compound that inhibits thrombin, the final step in the clotting activation pathway.

Release details: Model release not required. Property release not required.

Keywords: anticoagulant, artwork, biochemical, biochemistry, chemical, chemistry, compound, computer artwork, direct thrombin inhibitor, drug, exanta, illustration, melagatran, molecular, molecule, pharmaceutical, pharmaceutics, pharmacological, pharmacology, prodrug, rod, rods, ximelagatran

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.